RAPT Therapeutics Inc (RAPT) Ownership

17.77 ↑0.25 (1.43%)
As of December 2, 2022, 11:23am EST.

Institutional Ownership

T. Rowe Price Associates, Inc. is the biggest individual institutional holder of RAPT Therapeutics Inc (RAPT), owning a total of 4.3 million shares. Combined, the top 20 institutional holders of RAPT own 81.19% of the company with a total of 24.3 million shares.

In the latest ownership report on September 30th 2022, the top 20 institutional holders increased their combined ownership of RAPT by 881 thousand shares. 6 institutions bought 1,529,420 total additional shares and increased their ownership by an average of 37.55%. However 1 institutions sold 648,532 total shares and decreased their ownership by an average of 50%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of RAPT Therapeutics increased by a net total of 880,888 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Column Group LLC8.969%0.000%2,680,45802022-09-30
Ponoi Management, LLC5.352%0.000%1,599,41702022-09-30
Vanguard Group Inc4.296%1.451%1,283,90818,3632022-09-30
State Street Corporation4.263%159.520%1,273,891783,0262022-09-30
Woodline Partners LP4.044%40.684%1,208,485349,4772022-09-30
KPCB XV Associates LLC2.170%-50.000%648,531-648,5322022-09-30
Euclidean Capital LLC1.449%0.000%432,90002022-09-30
Great Point Partners LLC1.054%0.000%315,000315,0002022-09-30
Candriam Luxembourg S.C.A.1.048%18.487%313,26248,8772022-09-30
Dimensional Fund Advisors, Inc.1.000%5.163%298,97514,6772022-09-30

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
T. Rowe Price Associates, Inc.14.504%9.057%4,334,683359,9782022-06-30
FMR Inc13.706%28.701%4,096,166913,4652022-06-30
Column Group LLC8.969%0.000%2,680,45802022-09-30
Perceptive Advisors LLC6.404%-31.649%1,913,791-886,1712022-06-30
Ponoi Management, LLC5.352%0.000%1,599,41702022-09-30
Vanguard Group Inc4.296%1.451%1,283,90818,3632022-09-30
State Street Corporation4.263%159.520%1,273,891783,0262022-09-30
Woodline Partners LP4.044%40.684%1,208,485349,4772022-09-30
Kingdon Capital Management LLC3.424%-5.973%1,023,321-65,0002022-06-30
Orbimed Advisors, LLC2.899%139.800%866,396505,0962022-06-30
Redmile Group, LLC2.737%9.237%817,83269,1552022-06-30
KPCB XV Associates LLC2.170%-50.000%648,531-648,5322022-09-30
Euclidean Capital LLC1.449%0.000%432,90002022-09-30
Geode Capital Management, LLC1.360%9.671%406,43235,8412022-06-30
Great Point Partners LLC1.054%0.000%315,000315,0002022-09-30
Candriam Luxembourg S.C.A.1.048%18.487%313,26248,8772022-09-30
Dimensional Fund Advisors, Inc.1.000%5.163%298,97514,6772022-09-30
Deutsche Bank AG0.967%0.270%289,1147782022-06-30
Northern Trust Corp0.821%15.772%245,47133,4422022-06-30
Healthcor Management LP0.727%-17.787%217,165-46,9852022-06-30

Mutual Fund Ownership

T. Rowe Price New Horizons is the biggest individual fund holder of RAPT Therapeutics Inc (RAPT), owning a total of 1.6 million shares. Combined, the top 20 mutual fund holders of RAPT own 38.28% of the company with a total of 11.4 million shares.

In the latest ownership report on October 31st 2022, the top 20 fund holders increased their combined ownership of RAPT by 11 thousand shares. 3 funds bought 10,943 total additional shares and increased their ownership by an average of 0.71%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding RAPT Therapeutics increased by a net total of 10,943 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
SPDR® S&P Biotech ETF2.823%0.720%843,5296,0322022-10-31
Vanguard Total Stock Mkt Idx Inv2.524%0.000%754,45002022-10-31
iShares Russell 2000 ETF1.944%0.328%581,0701,9002022-10-31
Vanguard Extended Market Index Investor0.940%1.084%280,8063,0112022-10-31

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
T. Rowe Price New Horizons5.492%-0.088%1,641,446-1,4452022-09-30
Strategic Advisers® Fidelity US TtlStk3.956%-23.368%1,182,410-360,5642022-09-30
Fidelity® Select Biotechnology3.429%0.000%1,024,67702022-09-30
SPDR® S&P Biotech ETF2.823%0.720%843,5296,0322022-10-31
Vanguard Total Stock Mkt Idx Inv2.524%0.000%754,45002022-10-31
Vanguard Instl Ttl Stck Mkt Idx Tr2.524%0.031%754,4502332022-09-30
T. Rowe Price Health Sciences2.396%3.343%716,06023,1602022-09-30
iShares Russell 2000 ETF1.944%0.328%581,0701,9002022-10-31
FIAM Small Cap Core Class B1.905%11.363%569,40058,1002022-08-31
T. Rowe Price Small-Cap Stock1.604%-0.560%479,222-2,7002022-09-30
Biotech Growth Ord1.537%39.617%459,200130,3002022-07-31
FIAM Small Cap Core Composite1.155%18.098%345,20052,9002022-06-30
FIAM Small/Mid Cap Core II1.063%-4.424%317,600-14,7002022-08-31
Candriam Eqs L Biotech C USD Cap1.048%0.000%313,26202022-09-30
Vanguard Extended Market Index Investor0.940%1.084%280,8063,0112022-10-31
T. Rowe Price Instl Small-Cap Stock0.877%0.000%261,97902022-09-30
T. Rowe Price US Small-Cap Core Equity0.877%0.000%261,97902022-09-30
T. Rowe Price New Horizons Tr-Z0.810%0.601%242,0441,4452022-09-30
T. Rowe Price U.S. SC Core Eq Tr-Z0.707%7.849%211,38915,3852022-09-30
Fidelity® Small Cap Index0.671%2.752%200,3835,3672022-08-31

Discussions

Please log in or register to share your thoughts.

BretJohns

$RAPT id rather have a dip then rip than a gap and crap

0 Like Report
wsb_pro

$RAPT Nothing but time to wait

0 Like Report